Home › Funds › ACT CAPITAL MANAGEMENT, LLC › NKTR

ACT CAPITAL MANAGEMENT, LLC position in NKTR

NEKTAR THERAPEUTICS COM NEW · Health Care

ACT CAPITAL MANAGEMENT, LLC reported holding 89,300 shares of NKTR (NEKTAR THERAPEUTICS COM NEW) in its Q2 2026 13F filing — a position valued at US$6.2M, representing 4.07% of its reported portfolio and ranking #9 among its reported holdings. ACT CAPITAL MANAGEMENT, LLC has disclosed NKTR holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)89.30K sh
Reported value held$6.23M
Portfolio Weight4.07%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ACT CAPITAL MANAGEMENT, LLC's NKTR position evolved

ACT CAPITAL MANAGEMENT, LLC first disclosed a stake in NKTR in Q4 2025 at 51,200 shares (US$2.2M). The position peaked in Q2 2026 at 89,300 shares, worth US$6.2M. Across 3 filings, ACT CAPITAL MANAGEMENT, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 89,300 shares valued at US$6.2M — an increase of 18,400 shares quarter over quarter.. Notable position changes include a 38% increase in Q1 2026 (shares fell 3% over the following quarter), a 26% increase in Q2 2026 (shares fell 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 51.20K $2.16M New
Q1 2026 70.90K $5.10M Add
Q2 2026 89.30K $6.23M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NKTR and 13F data

NKTR (NEKTAR THERAPEUTICS COM NEW) is a Health Care company. 70 other funds we track also report a position in NKTR — the largest reported positions include Two Seas Capital LP (US$202.6M), BVF INC/IL (US$166.9M), Vestal Point Capital, LP (US$69.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NKTR

All NKTR fund holders →

FAQ

How long has ACT CAPITAL MANAGEMENT, LLC held NKTR?

ACT CAPITAL MANAGEMENT, LLC has disclosed NKTR holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is ACT CAPITAL MANAGEMENT, LLC's current position in NKTR?

As of Q2 2026, ACT CAPITAL MANAGEMENT, LLC holds 89.30K shares of NKTR (NEKTAR THERAPEUTICS COM NEW), valued at $6.23M, representing 4.07% of its reported portfolio and ranking #9.

Has ACT CAPITAL MANAGEMENT, LLC been buying or selling NKTR?

In the latest 13F filing (Q2 2026), ACT CAPITAL MANAGEMENT, LLC increased its position in NKTR. The position peaked in Q2 2026 at 89.30K shares.

Which other funds hold NKTR?

Other major institutional holders of NKTR include Two Seas Capital LP, BVF INC/IL, Vestal Point Capital, LP, among 70 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.